50
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0488 |
Finasteride
非那雄胺,MK-906 |
Reductase | Endocrinology/Hormones; Metabolism |
Finasteride (MK-906) 是 5α-还原酶的竞争性抑制剂,对 II 型 5α-还原酶的IC50为 4.2 nM,对 II 型 5α-还原酶的亲和力是 I 型酶的 100 倍。它可用于研究前列腺增生和雄激素性脱发。 | |||
T0696 |
Naftopidil
KT-611,萘哌地尔,BM-15275 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Naftopidil (KT-611) 是一种选择性的 alpha1-肾上腺素受体 (α1-adrenoceptor) 拮抗剂,对克隆的人类 α1a、α1b 和 α1d 亚型肾上腺素受体的亲和力Ki 分别为 3.7 nM、20 nM 、1.2 nM。它具有抗增殖活性,可用于研究前列腺增生。 | |||
T1504 |
Silodosin
西洛多辛,KAD 3213,KMD 3213 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Silodosin (KAD 3213) 是有选择性的、强效的、口服活性的 α1A-adrenergic receptor 阻滞剂,是一种有效且耐受性良好的试剂,可用于研究 LUTS/BPH。它对 α1A-AR 表现出高度的亲和力,是 α1B-AR 和 α1D-AR 亲和力的 162 和 50 倍。 | |||
T0197 |
Terazosin hydrochloride
盐酸特拉唑嗪,Terazosin HCl,Terazosine,Blavin,Hytrin,Zayasel,Fosfomic |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Terazosin hydrochloride (Hytrin) 是一种竞争性和口服活性的 α1-肾上腺素受体拮抗剂,是一种喹唑啉衍生物。它通过舒张血管和打开膀胱来起作用。它可用于良性前列腺增生和高血压的研究。 | |||
T6600 |
Naftopidil dihydrochloride
KT-611,KT-611 2HCl,盐酸萘哌地尔,Naftopidil DiHCl |
5-HT Receptor; Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Naftopidil dihydrochloride (KT-611 2HCl) 是一种选择性的 alpha1-肾上腺素受体 (α1-adrenoceptor) 拮抗剂,对克隆的人类 α1a、α1b 和 α1d 亚型肾上腺素受体的亲和力Ki 分别为 3.7 nM、20 nM、1.2 nM。它具有抗增殖活性,可用于研究前列腺增生。 | |||
T6701 |
Terazosin hydrochloride dihydrate
Flotrin dihydrate,Terazosin HCl Dihydrate,Dysalfa dihydrate,Heitrin dihydrate,盐酸特拉唑嗪(二水合物) |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Terazosin hydrochloride dihydrate (Heitrin dihydrate) 是一种竞争性和口服活性的 α1-肾上腺素受体(α1-adrenoceptor) 拮抗剂,是一种喹唑啉衍生物,通过舒张血管和打开膀胱的方式起作用。它可用于研究良性前列腺增生 (BPH) 和高血压。 | |||
T6461 |
Dapoxetine hydrochloride
LY-210448,LY-210448 hydrochloride,Dapoxetine HCl,盐酸达泊西汀,Priligy |
5-HT Receptor; Serotonin Transporter | GPCR/G Protein; Neuroscience |
Dapoxetine hydrochloride (LY-210448 hydrochloride) 是一种具有口服活性的、选择性的血清素再摄取 (serotonin reuptake) 抑制剂 (SSRI),可用于研究早泄 (PE) 。 | |||
T9220 |
Naftopidil hydrochloride
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-,萘哌地尔盐酸盐,KT-611 hydrochloride,BM-15275 hydrochloride |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Naftopidil hydrochloride (BM-15275 hydrochloride) 是一种选择性的 alpha1-肾上腺素受体 (α1-adrenoceptor) 拮抗剂,对克隆的人类 α1a、α1b 和 α1d 亚型肾上腺素受体的亲和力 Ki 分别为 3.7 nM、20 nM、1.2 nM。它具有抗增殖活性,可用于研究前列腺增生。 | |||
T0039 |
Dapoxetine
达波西汀,Dapoxetina,Dapoxetinum |
Others; 5-HT Receptor | GPCR/G Protein; Neuroscience; Others |
Dapoxetine (Dapoxetina) 是一种选择性5-羟色胺再摄取抑制剂,用于治疗早泄。 | |||
T13703 |
Gestonorone Capronate
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Gestonorone Capronate 是一种孕激素,在良性前列腺肥大和子宫内膜癌领域有研究价值。 | |||
T14843 |
Bifluranol
BX341 |
Androgen Receptor | Endocrinology/Hormones |
Bifluranol (BX341) 具有抗雄激素活性,在体内实验中显示出显著的抗前列腺活性,可用于治疗良性前列腺增生 (BPH)。 | |||
T31095 |
Crinecerfont
SSR125543,SSR 125543,SSR-125543,SSR125543A,SSR 125543A,SSR-125543A |
CRFR | GPCR/G Protein |
Crinecerfont (SSR-125543) 是促肾上腺皮质激素释放因子 1 受体 (CRF1) 的特异性拮抗剂,可用于经典先天性肾上腺增生的研究。 | |||
T22316 |
Doxazosin
UK 33274,多沙唑嗪 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Doxazosin (UK 33274) 是选择性的拮抗突触后的α1肾上腺素受体。 | |||
T76978 |
Siltuximab
CNTO-328 |
IL Receptor | Immunology/Inflammation |
Siltuximab(CNTO-328) 是一种靶向 IL-6 且具有抗肿瘤活性的单克隆抗体,可用于研究巨大淋巴结增生症 (MCD) 和 COVID-19。 | |||
T27798 |
Lapisteride
CS891B,CS-891,CS-891B,CS891 |
Others | Others |
Lapisteride (CS-891) 一种类固醇5α-还原酶抑制剂,可用于治疗良性前列腺增生(BPH)和雄激素性脱发,可有效预防或治疗AGA 。 | |||
T28922 |
Taprizosin
Taprizosin Mesylate,UK-338003,UK-338,003,UK338003,UK 338003 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Taprizosin(UK-338003)是一种具有选择性和口服活性的 α1-肾上腺素受体 (α1-adrenoceptor) 拮抗剂,可用于舒张血管,用于治疗良性前列腺增生症。 | |||
T15688 |
L-771688
SNAP 6383 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
L-771688(SNAP 6383) 是一种新型有效和选择性的 α1A-肾上腺素受体拮抗剂, Ki 值为 0.43±0.02 nM。L-771688 KE 用于治疗良性前列腺增生。 | |||
T26278 |
Tildacerfont
|
CRFR | GPCR/G Protein |
Tildacerfont 是 CRF1 的拮抗剂,可降低促肾上腺皮质激素和肾上腺雄激素的水平。 Tildacerfont 可用于先天性肾上腺增生的研究。 | |||
T0091 |
Alfuzosin hydrochloride
SL 77499-10,Alfuzosin HCl,盐酸阿夫唑嗪 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Alfuzosin hydrochloride (Alfuzosin HCl) 是一种 α1 肾上腺素受体拮抗剂,可用于良性前列腺增生(BPH)的研究。 | |||
T1499 |
Dutasteride
GG 745,Avodart,度他雄胺,GI 198745 |
Apoptosis; Reductase | Apoptosis; Endocrinology/Hormones; Metabolism |
Dutasteride (GI 198745) 是一种 5α 还原酶同工酶抑制剂,还可能因其结构域 DHT 相似对雄激素受体产生脱靶效应。 | |||
T35182 |
Xinidamine
BRN 0891979,Xinidaminum,Xinidamino |
||
Xinidamine (BRN 0891979) 具有抗肿瘤活性,可用于研究良性前列腺增生、黄斑变性和前列腺上皮内瘤 。Xinidamine 对PWR-1E 细胞的增殖具有抑制作用,IC50为4μM。 | |||
T11286 |
Fiduxosin
A 185980.1,ABT 980 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Fiduxosin 是一种具有选择性和有效性的 α1-adrenoceptor 拮抗剂,对 α1a-adrenoceptor,α1b-adrenoceptor 和 α1d-adrenoceptor 有抑制作用,Ki 值分别为 0.160 nM,24.9 nM 和 0.920 nM。Fiduxosin 可用于治疗良性前列腺增生。 | |||
T0210L |
Tamsulosin
LY253351 free base,HSDB7744,(R)-(-)-YM12617 free base,Harnal-D,Flowmax,HSDB 7744,HSDB-7744 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Tamsulosin ((R)-(-)-YM12617 free base) 是一种肾上腺素能受体α 1A 拮抗剂,用于良性前列腺增生(BPH)的治疗。Tansulosin 用于治疗排尿困难,这是前列腺肥大的一种常见症状。Tansulosin 和其他被称为α受体阻滞剂的药物通过放松膀胱颈部肌肉和前列腺本身的肌肉纤维来发挥作用,使其更容易排尿。 | |||
T68123 |
Oxodipine
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Oxodipine 是一种二氢吡啶型钙拮抗剂 ,抑制了KCl 诱导的兔主动脉收缩,降低了效力较低的大鼠心室试纸收缩的心脏力量。在大鼠培养的新生儿心室肌细胞中,Oxodipine 降低了L 型Ca 电流(I),IC 为0.24μM,对T 型Ca 电流(I)的IC 为0.41μM。Oxodipine 会使小鼠便秘和狗牙龈增生。 | |||
T22232 |
Alfuzosin
|
||
Alfuzosin 是选择性和竞争性的α1肾上腺素受体拮抗剂,可用于良性前列腺增生(BPH)的研究。 | |||
T70396 | Fexapotide triflutate | ||
Fexapotide triflutate is a caspase and TNF signaling pathway activator used to treat benign prostatic hyperplasia (BPH). | |||
T28956 |
TF-505
FR-146687,FK-687,TF 505,FK687 |
||
TF-505, a steroid 5α-reductase inhibitor, is used potentially for the treatment of benign prostatic hyperplasia. | |||
T20024 |
Tadalafil, (6R ,12aS)-
Tadalafil (6R ,12aS)- Lilly,Tadalafil specified impurity A,(-)-Tadalafil (6R ,12aS) diastereomer |
||
Tadalafil is a carboline derivative and Phosphodiesterase 5 Inhibitor. It is used primarily to treat Erectile dysfunction, Benign Prostatic Hyperplasia, and Primary Pulmonary Hypertension. | |||
T33826 |
Osaterone
|
||
Osaterone is effective against prostatic hyperplasia in dogs. | |||
T32029 |
GYKI-16084
GYKI 16084 |
||
GYKI-16084 is a postsynaptic alpha2 receptor blocker with potential efficacy in the treatment of benign prostatic hyperplasia. | |||
T71793 |
CDMG1
|
||
CDMG1 is a novel Wnt inhibitor, promoting heart regeneration, injury repair, and myocardial hyperplasia through expansion of the cardiac progenitor cell population | |||
T24378 |
L-771688 dihydrochloride
L 771688 dihydrochloride |
||
L-771688 is an α1A-adrenoceptor antagonist potentially for the treatment of benign prostatic hyperplasia. | |||
T38697 |
[Tyr(P)4] Angiotensin II
|
||
[Tyr(P)4] Angiotensin II is a peptide that exerts a multitude of effects on vascular smooth muscle. These effects include the contraction of normal arteries, as well as the induction of hypertrophy or hyperplasia in cultured cells or diseased vessels. | |||
T40398 |
Crinecerfont hydrochloride
SSR-125543A,SSR-125543 hydrochloride |
||
Crinecerfont hydrochloride (SSR-125543) is a highly potent, orally active, non-peptide antagonist of the CRF1 receptor. It has demonstrated efficacy in the context of Classic congenital adrenal hyperplasia (CAH) research. | |||
T3290L |
Pikamilone Sodium
GABA-NG,Nicotinoyl-GABA sodium salt,GABA NG,GABANG,Pikamilone Na |
||
Pikamilone Sodium is a prodrug of GABA used for therapy of neurogenic bladder in spinal and benign prostatic hyperplasia. | |||
T69927 | Fiduxosin hydrochloride | ||
Fiduxosin hydrochloride is an alpha 1a-adrenoceptor antagonist that may be useful in the treatment of Benign Prostatic Hyperplasia. | |||
TP1224 |
[Sar1, Ile8]-Angiotensin II TFA
Angiotensin 2 TFA,AngiotensinII TFA |
||
[Sar1, Ile8]-Angiotensin II (TFA) is a peptide compound that exerts various effects on vascular smooth muscle. These effects include the contraction of normal arteries as well as the hypertrophy or hyperplasia of cultured cells or diseased vessels. | |||
T61729 |
Terazosin
|
||
Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of α1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3]. | |||
T79793 |
CRF1 receptor antagonist-1
|
CFTR | Membrane transporter/Ion channel |
CRF1 receptor antagonist-1 (Compound 2)为CRF1受体拮抗剂,适用于先天性肾上腺增生症(CAH)的研究领域。 | |||
T28245 |
ONO-0300302
ONO 0300302 |
||
ONO-0300302 is a slow tight binding LPA1 antagonist (IC50: 0.16 nM) used to treat Benign Prostatic Hyperplasia. ONO-0300302 inhibits significantly an LPA-induced increase of intraurethral pressure (IUP) in rat (3 mg/kg, p.o.) and dog (1 mg/kg, p.o.) over | |||
T35665 |
Pregnanetriol
|
||
Pregnanetriol is a metabolite of 17α-hydroxyprogesterone .1,2It is formed from 17α-hydroxyprogesterone by reduction of the C-20 ketone.2Urinary levels of pregnanetriol are elevated in patients with 21-hydroxylase deficiency and congenital adrenal hyperplasia.3,4 1.Kamrath, C., Hartmann, M.F., Boettcher, C., et al.Diagnosis of 21-hydroxylase deficiency by urinary metabolite ratios using gas chromatography-mass spectrometry analysis: Reference values for neonates and infantsJ. Steroid Biochem. Mol... | |||
T83428 |
1-Myristoyl-3-chloropropanediol
|
||
1-Myristoyl-3-chloropropanediol 是一种MCPD (3-一氯丙二醇) 脂肪酸酯。慢性口服该化合物可导致肾病、小管增生和腺瘤形成,在大鼠中也观察到生育能力下降,不育发生率增加,以及免疫功能受到抑制。 | |||
T35519 |
Aflatoxin B2-13C17
Aflatoxin B2-13C17 |
||
Aflatoxin B2-13C17(AFB2-13C17) is intended for use as an internal standard for the quantification of AFB2by GC- or LC-MS. AFB2is a mycotoxin that has been found inA. terricola.1It induces hepatic autophagy and apoptosis in broiler chickens when administered at doses of 0.2, 0.4, and 0.8 mg/kg.2AFB2(0.5 and 1 mg/animal) also induces parenchymal cell hyperplasia in rats.3 1.Moubasher, A.H., el-Kady, I.A., and Shoriet, A.Toxigenic Aspergilli isolated from different sources in EgyptAnn. Nutr. Alimen... | |||
T76275 |
Fexapotide
|
||
Fexapotide (NX-1207 free acid) 在细胞水平上通过选择性诱导细胞凋亡,降低前列腺体积。它主要用于研究下尿路症状(LUTS)与良性前列腺增生(BPH)。 | |||
T21814 |
ONO 4817
|
||
ONO-4817 是一种广谱基质金属蛋白酶 (MMP) 抑制剂。抑制基质金属蛋白酶 (MMP) 有望抑制动脉粥样硬化新内膜增殖,从而限制动脉粥样硬化斑块的进展。ONO-4817 抑制实验性高脂血症兔主动脉内膜增生的发展。 | |||
T37983 |
GM 1489
|
||
GM 1489 is a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) with Ki values of 0.002, 0.1, 0.5, 0.2, and 20 μM for MMP-1, MMP-8, MMP-2, MMP-9, and MMP-3, respectively. It reduces 5-aza-2'-deoxycytidine-induced increases in MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, and MMP-14 expression as well as cell invasion in AsPC-1, BxPC-3, Hs766T, MiaPaCa2, and PANC-1 cancer cells. Topical administration of GM 1489 (100 μg) inhibits increases in ear thickness and epidermal hyperplasia induced by phor... | |||
T76242 |
MMI-0100
|
||
MMI-0100 是一种细胞渗透性肽抑制剂,抑制丝裂原活化蛋白激酶活化蛋白激酶 II (MK2)。MMI-0100 在体内外减少内膜增生。MMI-0100 抑制IL-6表达而不影响IL-8表达。MMI-0100 抑制纤维化过程,例如静脉移植疾病。 | |||
T21668 | Finasteride acetate | ||
Finasteride (MK-906) acetate 是一种高效的5α-还原酶 (5α-reductase) 竞争性抑制剂,其对 II 型 5α-还原酶的IC50值仅为 4.2 nM,其对该型酶的亲和力是对 I 型酶亲和力的约100倍。因此,Finasteride acetate 主要在良性前列腺增生症 (BPH) 和雄激素性脱发研究领域中应用。 | |||
T36380 |
GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt)
|
||
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and truncated GLP-1 (7-36) amide , in pancreatic tissue compared to wild-type mice.2References1. Schjoldager, B.T., Mortensen, P.E., Christiansen, J., et al. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans... | |||
T35579 | PKSI-527 | ||
PKSI-527 is an inhibitor of plasma kallikrein (Ki = 0.81 μM). It is selective for plasma kallikrein over glandular kallikrein, plasmin, thrombin, urokinase, and Factor Xa (Kis = >500, 390, >500, 200, and >500 μM, respectively). PKSI-527 reduces bradykinin generation induced by kaolin and λ-carrageenan ex vivo in human plasma. It also prolongs partial thromboplastin and euglobulin clot lysis times. In vivo, PKSI-527 (300 mg/kg per day) reduces hyperplasia, pannus formation, and infiltration of in... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5031 |
Sitostenone
豆甾-4-烯-3-酮 |
Others | Others |
Sitostenone 具有抗氧化活性。 Stigmasta-4-en-3-one(Sitostenone)可用于治疗雄激素依赖性疾病,尤其是治疗良性前列腺增生。 | |||
T36915 |
21-Deoxycortisol
|
||
21-Deoxycortisol is a corticosteroid metabolite of 17-hydroxyprogesterone produced in the adrenal glandvia11-hydroxylation by 11β-hydroxylase.1,2Serum levels of 21-deoxycortisol are elevated in patients with congenital adrenal hyperplasia that are heterozygous for mutations inCYP2A21, the gene encoding steroid 21-hydroxylase, and have been used as a biomarker for the detection of 21-hydroxylase deficiencies. 1.Fiet, J., Villette, J.-M., Galons, H., et al.The application of a new highly-sensitive... | |||
TN1061 | Ganoderol B | Androgen Receptor | Endocrinology/Hormones |
Ganoderol B is a potent β ±-glucosidase and angiotensin-converting enzyme inhibitor, with an IC(50) of β ±-glucosidase is 119.8 uM. It may be useful in prostate cancer and benign prostatic hyperplasia (BPH) therapy through suppressing the function of andr | |||
TN4582 |
Moracin T
|
c-Myc; COX | Cell Cycle/Checkpoint; Immunology/Inflammation; Neuroscience |
Moracin treatment can inhibit the double 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment-induced morphological changes reflecting inflammatory response, including leucocyte infiltration, hyperplasia and cell proliferation; moracin treatment furthermo | |||
TN4819 | (-)-Praeruptorin A | ATPase; IL Receptor; Calcium Channel; P-gp | Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; Neuroscience |
(-)-Praeruptorin A has anti-inflammatory, anti-contractile and anti-hyperplasia activities, it exerts distinct relaxant effects on isolated rat aorta rings dependent on endothelium and nitric oxide synthesis;it also can significantly suppress airway inflammation and airway remodeling induced by ovalbumin challenge, and is a potential candidate for the treatment of asthma. (-)-Praeruptorin A resensitizes Pgp-mediated MDR (Pgp-MDR) cancer cells to cancer drugs. |